Rocket Pharmaceuticals Announces FDA Alignment on Path to Complete Pivotal Phase 2 Trial of RP-A501 in Danon Disease
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: RCKT) | Delayed: 2.20 -0.14 (5.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.34 | 52 Week High | $ | |||
| Open | $2.34 | 52 Week Low | $ | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.17 | EPS | $ | |||
| Volume | 2,023,724 | |||||
